Editing Fibromyalgia notable studies

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.

The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then publish the changes below to finish undoing the edit.

Latest revision Your text
Line 34: Line 34:
*2011, [https://doi.org/10.1186/1477-7525-9-71 The comparative burden of mild, moderate and severe Fibromyalgia: results from a cross-sectional survey in the United States]<ref name="Schaefer2011">{{Cite journal | last = Schaefer | first = Caroline | last2 = Chandran | first2 = Arthi | last3 = Hufstader | first3 = Meghan | last4 = Baik | first4 = Rebecca | last5 = McNett | first5 = Michael | last6 = Goldenberg | first6 = Don | last7 = Gerwin | first7 = Robert | last8 = Zlateva | first8 = Gergana | date = 2011-08-22 | title = The comparative burden of mild, moderate and severe Fibromyalgia: results from a cross-sectional survey in the United States| url = https://doi.org/10.1186/1477-7525-9-71|journal=Health and Quality of Life Outcomes|volume=9|issue=1 | pages = 71|doi=10.1186/1477-7525-9-71|issn=1477-7525|pmc=3179696|pmid=21859448}}</ref>
*2011, [https://doi.org/10.1186/1477-7525-9-71 The comparative burden of mild, moderate and severe Fibromyalgia: results from a cross-sectional survey in the United States]<ref name="Schaefer2011">{{Cite journal | last = Schaefer | first = Caroline | last2 = Chandran | first2 = Arthi | last3 = Hufstader | first3 = Meghan | last4 = Baik | first4 = Rebecca | last5 = McNett | first5 = Michael | last6 = Goldenberg | first6 = Don | last7 = Gerwin | first7 = Robert | last8 = Zlateva | first8 = Gergana | date = 2011-08-22 | title = The comparative burden of mild, moderate and severe Fibromyalgia: results from a cross-sectional survey in the United States| url = https://doi.org/10.1186/1477-7525-9-71|journal=Health and Quality of Life Outcomes|volume=9|issue=1 | pages = 71|doi=10.1186/1477-7525-9-71|issn=1477-7525|pmc=3179696|pmid=21859448}}</ref>


*2012, [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394355/ Fibromyalgia Syndrome: An Overview of Pathophysiology, Diagnosis and Management]<ref name="Jahan2012">{{Cite journal | last = Jahan | first = Firdous | last2 = Nanji | first2 = Kashmira | last3 = Qidwai | first3 = Waris | last4 = Qasim | first4 = Rizwan | date = 2012  | title = Fibromyalgia Syndrome: An Overview of Pathophysiology, Diagnosis and Management| url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394355/|journal=Oman Medical Journal|volume=27|issue=3 | pages = 192–195|doi=10.5001/omj.2012.44|issn=1999-768X|pmc=|pmid=22811766|via=}}</ref>   
*2012, [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394355/ Fibromyalgia Syndrome: An Overview of Pathophysiology, Diagnosis and Management]<ref name="Jahan2012">{{Cite journal | last = Jahan | first = Firdous | last2 = Nanji | first2 = Kashmira | last3 = Qidwai | first3 = Waris | last4 = Qasim | first4 = Rizwan| date = 2012  | title = Fibromyalgia Syndrome: An Overview of Pathophysiology, Diagnosis and Management| url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394355/|journal=Oman Medical Journal|volume=27|issue=3 | pages = 192–195|doi=10.5001/omj.2012.44|issn=1999-768X|pmc=|pmid=22811766|via=}}</ref>   
<blockquote>Pathophysiology: Although the etiology remains unclear, characteristic alterations in the [[Sleep dysfunction|pattern of sleep]] and changes in neuroendocrine transmitters such as [[serotonin]], [[substance P]], growth hormone and [[cortisol]] suggest that regulation of the [[Autonomic nervous system|autonomic]] and neuro-endocrine system appears to be the basis of the syndrome. Fibromyalgia is not a life-threatening, deforming, or progressive disease. [[Anxiety]] and [[depression]] are the most common association. Aberrant pain processing, which can result in [[chronic pain]], may be the result of several interplaying mechanisms. [[Central sensitization]], blunting of inhibitory pain pathways and alterations in [[neurotransmitter]]s lead to aberrant neuro-chemical processing of sensory signals in the [[central nervous system|CNS]], thus lowering the threshold of pain and amplification of normal sensory signals causing constant pain.<ref name="Jahan2012" /></blockquote><blockquote>The frequent co-morbidity of fibromyalgia with mood disorders suggests a major role for the stress response and for [[neuroendocrine system|neuroendocrine]] abnormalities. The [[hypothalamic pituitary axis]] (HPA) is a critical component of the stress-adaptation response. In FMS, stress adaptation response is disturbed leading to stress induce symptoms. Psychiatric co-morbidity has been associated with FMS and needs to be identified during the consultation process, as this requires special consideration during treatment.<ref name="Jahan2012" /></blockquote>
<blockquote>Pathophysiology: Although the etiology remains unclear, characteristic alterations in the [[Sleep dysfunction|pattern of sleep]] and changes in neuroendocrine transmitters such as [[serotonin]], [[substance P]], growth hormone and [[cortisol]] suggest that regulation of the [[Autonomic nervous system|autonomic]] and neuro-endocrine system appears to be the basis of the syndrome. Fibromyalgia is not a life-threatening, deforming, or progressive disease. [[Anxiety]] and [[depression]] are the most common association. Aberrant pain processing, which can result in [[chronic pain]], may be the result of several interplaying mechanisms. [[Central sensitization]], blunting of inhibitory pain pathways and alterations in [[neurotransmitter]]s lead to aberrant neuro-chemical processing of sensory signals in the [[central nervous system|CNS]], thus lowering the threshold of pain and amplification of normal sensory signals causing constant pain.<ref name="Jahan2012" /></blockquote><blockquote>The frequent co-morbidity of fibromyalgia with mood disorders suggests a major role for the stress response and for [[neuroendocrine system|neuroendocrine]] abnormalities. The [[hypothalamic pituitary axis]] (HPA) is a critical component of the stress-adaptation response. In FMS, stress adaptation response is disturbed leading to stress induce symptoms. Psychiatric co-morbidity has been associated with FMS and needs to be identified during the consultation process, as this requires special consideration during treatment.<ref name="Jahan2012" /></blockquote>


Please make sure your edits are consistent with MEpedia's guidelines. By saving changes, you agree to the Terms of use, and you irrevocably agree to release your contribution under the CC BY-SA 3.0 License and the GFDL. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel Editing help (opens in new window)